Nathalie Labrecque

11PUBLICATIONS
51CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Genetic immunologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 15, 2025
Blockade of colon cancer metastasis via single and double silencing of PCSK7/PCSK9: enhanced T cells cytotoxicity in mouse and human.

Chloé Porcheron, Mailys Le Devehat, Anna Roubtsova

|Mar 20, 2025
Early Notch signals from fibroblastic reticular cells program effector CD8+ T cell differentiation.

Dave Maurice De Sousa, Eric Perkey, Laure Le Corre

|Dec 21, 2022
Regulation of Cytotoxic CD8+ T Cells by the Circadian Clock.

Nicolas Cermakian, Nathalie Labrecque

|Jan 18, 2022
The Idd2 Locus Confers Prominent Resistance to Autoimmune Diabetes.

Félix Lombard-Vadnais, Roxanne Collin, Jean-François Daudelin

|Jul 27, 2021
NR4A3 Mediates Thymic Negative Selection.

Salix Boulet, Livia Odagiu, Mengqi Dong

|Sep 11, 2020
Early programming of CD8+ T cell response by the orphan nuclear receptor NR4A3.

Livia Odagiu, Salix Boulet, Dave Maurice De Sousa

Pageof 2

Frequent Collaborators

3 joint publications

Ivan Maillard

2 joint publications

Dave Maurice De Sousa

2 joint publications

Bruce R Blazar

2 joint publications

Todd V Brennan